Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongmeng Li

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Cell and Developmental Biology|September 19, 2022
Corrigendum: Negatively regulated by miR-29c-3p, MTFR1 promotes the progression and glycolysis in lung adenocarcinoma via the AMPK/mTOR signalling pathwayYongmeng Li, Yanfei Liu, Kai Jin, et al.
World Journal of Surgical Oncology|July 27, 2024
Nomograms to predict tumor regression grade (TRG) and ypTNM staging in patients with locally advanced esophageal cancer receiving neoadjuvant therapyJianhao Qiu, Zhan Zhang, Junjie Liu, et al.
Frontiers in Cell and Developmental Biology|December 20, 2021
Negatively Regulated by miR-29c-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma <i>via</i> the AMPK/mTOR Signalling PathwayYongmeng Li, Yanfei Liu, Kai Jin, et al.
Journal of Thoracic Disease|May 17, 2023
Cyclin O promotes lung cancer progression and cetuximab resistance via cell cycle regulation and <i>CDK13</i> interactionJin Jiang, Wenhao Yu, Tao Fang, et al.
International Journal of Oncology|March 31, 2021
Oncogenic role of abnormal spindle‑like microcephaly‑associated protein in lung adenocarcinomaJiang Wang, Jinghui Liang, Haixia Li, et al.
Cell Death & Disease|August 15, 2020
Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathwayJinghui Liang, Haixia Li, Jingyi Han, et al.
NPJ Precision Oncology|June 19, 2025
Accurate prediction of disease-free and overall survival in non-small cell lung cancer using patient-level multimodal weakly supervised learningYongmeng Li, Xiaodong Chai, Moxuan Yang, et al.
Journal of Translational Medicine|August 19, 2025
Multimodal prediction of tyrosine kinase inhibitors therapy outcomes in advanced EGFR-mutated NSCLC patientsXiaodong Chai, Hongxia Li, Moxuan Yang, et al.
Translational Lung Cancer Research|May 20, 2021
Let-7b-3p inhibits tumor growth and metastasis by targeting the BRF2-mediated MAPK/ERK pathway in human lung adenocarcinomaYongmeng Li, Rui Dong, Ming Lu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2026
ZBTB21 Is a Dual Suppressor of Pyroptosis and MHC-I Antigen Presentation That Promotes Tumor Immune EvasionLei Zhao, Linlin Sheng, Jianhao Qiu, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Cell and Developmental Biology|September 19, 2022
Corrigendum: Negatively regulated by miR-29c-3p, MTFR1 promotes the progression and glycolysis in lung adenocarcinoma via the AMPK/mTOR signalling pathwayYongmeng Li, Yanfei Liu, Kai Jin, et al.
World Journal of Surgical Oncology|July 27, 2024
Nomograms to predict tumor regression grade (TRG) and ypTNM staging in patients with locally advanced esophageal cancer receiving neoadjuvant therapyJianhao Qiu, Zhan Zhang, Junjie Liu, et al.
Frontiers in Cell and Developmental Biology|December 20, 2021
Negatively Regulated by miR-29c-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma <i>via</i> the AMPK/mTOR Signalling PathwayYongmeng Li, Yanfei Liu, Kai Jin, et al.
Journal of Thoracic Disease|May 17, 2023
Cyclin O promotes lung cancer progression and cetuximab resistance via cell cycle regulation and <i>CDK13</i> interactionJin Jiang, Wenhao Yu, Tao Fang, et al.
International Journal of Oncology|March 31, 2021
Oncogenic role of abnormal spindle‑like microcephaly‑associated protein in lung adenocarcinomaJiang Wang, Jinghui Liang, Haixia Li, et al.
Cell Death & Disease|August 15, 2020
Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathwayJinghui Liang, Haixia Li, Jingyi Han, et al.
NPJ Precision Oncology|June 19, 2025
Accurate prediction of disease-free and overall survival in non-small cell lung cancer using patient-level multimodal weakly supervised learningYongmeng Li, Xiaodong Chai, Moxuan Yang, et al.
Journal of Translational Medicine|August 19, 2025
Multimodal prediction of tyrosine kinase inhibitors therapy outcomes in advanced EGFR-mutated NSCLC patientsXiaodong Chai, Hongxia Li, Moxuan Yang, et al.
Translational Lung Cancer Research|May 20, 2021
Let-7b-3p inhibits tumor growth and metastasis by targeting the BRF2-mediated MAPK/ERK pathway in human lung adenocarcinomaYongmeng Li, Rui Dong, Ming Lu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2026
ZBTB21 Is a Dual Suppressor of Pyroptosis and MHC-I Antigen Presentation That Promotes Tumor Immune EvasionLei Zhao, Linlin Sheng, Jianhao Qiu, et al.
Pageof 3